Jan 13 (Reuters) – Drug distributor Cardinal Health on Tuesday forecast 2026 adjusted profit to be at least $10 per share, compared with its prior projection of $9.65 to $9.85 per share.
Analysts on average were expecting a profit of $9.83 per share, according to data complied by LSEG.
The increased forecast reflects the company’s strong performance across its five operating segments, it said.
Cardinal also said it has transitioned its manufacturer distribution service agreements for all branded drugs impacted by the 2026 Medicare Drug Price Negotiation Program.
(Reporting by Sneha S K; Editing by Shilpi Majumdar)
Comments